Publications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to: Focal Boosting in Localized Prostate Cancer in the Era of Systemic Therapy and Prostate-Specific Membrane Antigen Imaging.

01-04-2026

Maturitas

Long-term outcomes of surgical menopause after risk-reducing salpingo-oophorectomy: results of the HARMOny study.

01-04-2026

Future oncology (London, England)

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

01-04-2026

Clinical and translational science

Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology.

01-04-2026

Nature communications

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

01-04-2026

Annual review of immunology

Immune Niches in Cancer.

01-04-2026

Journal of cancer survivorship : research and practice

Identifying the informational needs and sources of support of Adolescent and Young Adult (AYA) cancer survivors to inform the development of a digital platform.

01-04-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

ESTRO's principles for environmental sustainability in the radiation oncology community.

01-04-2026

EMBO reports

Transcription elongation can be sufficient, but is not necessary, to advance replication timing.

01-04-2026

JCO precision oncology

Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma.

01-04-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Doubting T(h)OMAS: has the era of precision oncology arrived in uterine leiomyosarcoma?

01-04-2026

Cancer

Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.

01-04-2026

Journal of cancer survivorship : research and practice

"Numbers call for action, personalized narratives provide support and recognition": a qualitative assessment of cancer patients' perspectives on patient-reported outcome measures (PROMs) feedback with narratives.

01-04-2026

The Review of scientific instruments

Design and performance of an illumination-based hyperspectral laparoscopic system.

01-04-2026

Nature medicine

Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.

01-04-2026

Nature reviews. Immunology

Guidelines for T cell nomenclature.

01-04-2026

Journal of cancer survivorship : research and practice

Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position.

01-04-2026

International journal of computer assisted radiology and surgery

Navigated hepatic tumor resection using intraoperative ultrasound imaging.

01-04-2026

European urology oncology

Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer.

01-04-2026

Palliative medicine

Sexual health at the end of life in patients with advanced cancer and their partners. Results of a Dutch prospective longitudinal study (eQuiPe).

01-04-2026

European urology oncology

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

01-04-2026

European radiology

Improving membranous urethral length measurements on prostate MRI: a comparison of online training methods.

31-03-2026

Plastic and reconstructive surgery

A comparison of Breast Implant Illness-related symptoms between breast cancer survivors and breast augmentation recipients.

27-03-2026

Journal of medical genetics

Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care.

27-03-2026

European journal of cancer (Oxford, England : 1990)

Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.

26-03-2026

Journal of the National Cancer Institute

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

25-03-2026

Nature communications

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

25-03-2026

Frontiers in pharmacology

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region.

25-03-2026

Key Publication

Trends in cancer

Watching cancer begin: emerging tools to visualize the first steps of tumorigenesis.

24-03-2026

Journal of the National Cancer Institute

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

23-03-2026

Science translational medicine

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

18-03-2026

European radiology experimental

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

16-03-2026

Cancer research

C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

16-03-2026

International journal of cancer

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.

15-03-2026

European radiology experimental

Tumor morphology on CT radiomics is largely driven by the local anatomical environment, not the primary tumor type.

12-03-2026

Scientific data

A comprehensive European Colorectal Cancer Cohort dataset.

12-03-2026

European journal of cancer (Oxford, England : 1990)

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

11-03-2026

Journal of gastrointestinal cancer

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment.

10-03-2026

Journal of cancer survivorship : research and practice

Hospitalization for medical conditions in adolescent and young adult cancer survivors: a nationwide cohort study using the Netherlands Cancer Registry.

07-03-2026

Hepatology (Baltimore, Md.)

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

06-03-2026

Cell

CLIM-TIME links genetic cancer drivers to immune landscapes.

05-03-2026

Scientific reports

Evaluating mammographic density polygenic risk score for contralateral breast cancer risk prediction.

04-03-2026

Journal for immunotherapy of cancer

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

03-03-2026

Public health genomics

A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions.

02-03-2026

International journal of computer assisted radiology and surgery

Machine learning-based treatment outcome prediction in head and neck cancer using integrated noninvasive diagnostics.

01-03-2026

The Lancet. Oncology

Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.

01-03-2026

Nature cancer

Setting higher standards for reports of microbial species in human cancers.

01-03-2026

The Lancet. Oncology

MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.

01-03-2026

Abdominal radiology (New York)

Advancing MRI diagnostic practices in rectal cancer: exploring the impact of web-based multi-reader study participation.

01-03-2026

Nature medicine

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

01-03-2026

Reply to: Focal Boosting in Localized Prostate Cancer in the Era of Systemic Therapy and Prostate-Specific Membrane Antigen Imaging.

Long-term outcomes of surgical menopause after risk-reducing salpingo-oophorectomy: results of the HARMOny study.

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology.

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Immune Niches in Cancer.

Identifying the informational needs and sources of support of Adolescent and Young Adult (AYA) cancer survivors to inform the development of a digital platform.

ESTRO's principles for environmental sustainability in the radiation oncology community.

Transcription elongation can be sufficient, but is not necessary, to advance replication timing.

Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma.

Doubting T(h)OMAS: has the era of precision oncology arrived in uterine leiomyosarcoma?

Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.

"Numbers call for action, personalized narratives provide support and recognition": a qualitative assessment of cancer patients' perspectives on patient-reported outcome measures (PROMs) feedback with narratives.

Design and performance of an illumination-based hyperspectral laparoscopic system.

Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.

Guidelines for T cell nomenclature.

Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position.

Navigated hepatic tumor resection using intraoperative ultrasound imaging.

Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer.

Sexual health at the end of life in patients with advanced cancer and their partners. Results of a Dutch prospective longitudinal study (eQuiPe).

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Improving membranous urethral length measurements on prostate MRI: a comparison of online training methods.

A comparison of Breast Implant Illness-related symptoms between breast cancer survivors and breast augmentation recipients.

Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care.

Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region.

Watching cancer begin: emerging tools to visualize the first steps of tumorigenesis.

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.

Tumor morphology on CT radiomics is largely driven by the local anatomical environment, not the primary tumor type.

A comprehensive European Colorectal Cancer Cohort dataset.

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment.

Hospitalization for medical conditions in adolescent and young adult cancer survivors: a nationwide cohort study using the Netherlands Cancer Registry.

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

CLIM-TIME links genetic cancer drivers to immune landscapes.

Evaluating mammographic density polygenic risk score for contralateral breast cancer risk prediction.

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions.

Machine learning-based treatment outcome prediction in head and neck cancer using integrated noninvasive diagnostics.

Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.

Setting higher standards for reports of microbial species in human cancers.

MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.

Advancing MRI diagnostic practices in rectal cancer: exploring the impact of web-based multi-reader study participation.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

This site uses cookies